Our overarching goal is to understand the process of human placental trophoblast differentiation during the latter half of pregnancy, and the adaptive response of trophoblasts to injury. The clinical consequences of abnormal trophoblast differentiation and placental dysfunction are far-reaching, typically leading to intrauterine fetal death or fetal growth restriction. Newborns surviving these insults are at risk for lifelong complications, including neuro-developmental dysfunction and a greater incidence of the adult metabolic syndrome. Whereas the association of these conditions with placental dysfunction has been scrupulously substantiated, the mechanisms underlying trophoblast differentiation and adaptation to injury are poorly understood and insufficiently explored. Reflecting our poor understanding of the pathophysiology of fetal growth restriction, there is no effective treatment for this condition. The only intervention to prevent further fetal damage is delivery, which is designed to prevent further injury, yet commonly leads to prematurity. The recent discovery of microRNA (miRNA) adds a new dimension to cell-specific regulation of transcript and protein expression. Our knowledge of endogenous miRNA expression and its role in the development and function of mammalian tissues is rudimentary. Specifically, information regarding placental miRNA is scarce. Information gleaned from current studies in other tissues, bolstered by our own recent data, supports our hypothesis that the expression and function of discrete types of human placental miRNA govern trophoblast differentiation and adaptation to injury. Building on our preliminary data, we will mechanistically decipher the action of miRNAs that are regulated during trophoblast adaptation to injury. Through these analyses we seek to transform our understanding of trophoblast dysfunction during the second half of human pregnancy, and explore previously unknown pathways in trophoblast response to injury. Our proposal is unique, because (a) we focus on novel pathways of gene regulation that have not been interrogated thus far in the placenta, (b) we build our planned investigation on an unbiased, cutting edge technology in high-throughput miRNA-microarray analysis, combined with comprehensive mRNA arrays and proteomics, designed to define relevant miRNA targets in the placenta, and the regulatory function of these miRNA, and (c) we utilize innovative tools to establish a """"""""cause and effect"""""""" relationship, not mere associations. Our data will not only illuminate the molecular underpinning of trophoblast adaptation to injury, but may also lay the foundation to future translational research into novel diagnostic and therapeutic approaches for women with pregnancies complicated by placental dysfunction.

Public Health Relevance

As a sole-source provider of oxygen and nutrients to the developing embryo, the placenta is essential to fetal development. Our research is designed to elucidate the action of placental short RNA molecules (microRNAs) in adaptation of the placenta to external insults. Our experiments will broaden our understanding of placental diseases, and therefore illuminate origins of fetal and neonatal diseases, and their sequelae.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD065893-04
Application #
8484860
Study Section
Pregnancy and Neonatology Study Section (PN)
Program Officer
Ilekis, John V
Project Start
2010-08-15
Project End
2015-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
4
Fiscal Year
2013
Total Cost
$291,340
Indirect Cost
$38,880
Name
Magee-Women's Research Institute and Foundation
Department
Type
DUNS #
119132785
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Chang, Guojing; Mouillet, Jean-François; Mishima, Takuya et al. (2017) Expression and trafficking of placental microRNAs at the feto-maternal interface. FASEB J 31:2760-2770
Xie, Lan; Sadovsky, Yoel (2016) The function of miR-519d in cell migration, invasion, and proliferation suggests a role in early placentation. Placenta 48:34-37
Krawczynski, Kamil; Mishima, Takuya; Huang, Xin et al. (2016) Intact feto-placental growth in microRNA-210 deficient mice. Placenta 47:113-115
Mishima, Takuya; Sadovsky, Elena; Gegick, Margaret E et al. (2016) Determinants of effective lentivirus-driven microRNA expression in vivo. Sci Rep 6:33345
Mouillet, Jean-Francois; Mishima, Takuya; Paffaro, Andrea Mollica do Amarante et al. (2015) The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts. Placenta 36:1231-8
Chu, Tianjiao; Mouillet, Jean-Francois; Hood, Brian L et al. (2015) The assembly of miRNA-mRNA-protein regulatory networks using high-throughput expression data. Bioinformatics 31:1780-7
Sadovsky, Yoel; Mouillet, Jean-Francois; Ouyang, Yingshi et al. (2015) The Function of TrophomiRs and Other MicroRNAs in the Human Placenta. Cold Spring Harb Perspect Med 5:a023036
Mouillet, Jean-François; Ouyang, Yingshi; Coyne, Carolyn B et al. (2015) MicroRNAs in placental health and disease. Am J Obstet Gynecol 213:S163-72
Bayer, Avraham; Delorme-Axford, Elizabeth; Sleigher, Christie et al. (2015) Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol 212:71.e1-71.e8
Xie, Lan; Mouillet, Jean-Francois; Chu, Tianjiao et al. (2014) C19MC microRNAs regulate the migration of human trophoblasts. Endocrinology 155:4975-85

Showing the most recent 10 out of 17 publications